Latigo Biotherapeutics, Inc. (LTGO)
Form 4 sales, Form 144 notices and lockup dates Pharmaceutical Preparations, in Pharma.
- Latest sale
- None
- No Form 4 sale on record
- Form 4 sales
- 0
- On record
- Form 144 notices
- 0
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- Feb 2
- in 72 days · Assumed
Lockups
Feb 2, 2027
Ends in 72 days · Assumed date
- IPO lockupAssumed dateFeb 2, 2027 in 72 days
180 days from Aug 6, 2026. The prospectus also states 90 days.
Sales by reason
No Form 4 sale on record.
Timeline
- Feb 2, 2027Lockup ends, assumed
Lockup assumed to end Feb 2, 2027
- Nov 4, 2026Lockup ends, assumed
Lockup assumed to end Nov 4, 2026
2 of 2
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 10, 2026 | LTGO | Tananbaum James B. | Director, 10% owner | Bought | 140,000 | $18.00 | $2.5M | 2M | SEC |
| Aug 10, 2026 | Aug 10, 2026 | LTGO | Tananbaum James B. | Director, 10% owner | ConvertedSeries A-2 Convertible Stock | 9M | 0 | SEC | ||
| Aug 10, 2026 | Aug 10, 2026 | LTGO | Tananbaum James B. | Director, 10% owner | Converted | 9M | 3.4M | SEC | ||
| Aug 10, 2026 | Aug 12, 2026 | LTGO | 5AM Partners VI, LLC | 10% owner | ConvertedSeries A Preferred Stock | 7.3M | 0 | SEC | ||
| Aug 10, 2026 | Aug 12, 2026 | LTGO | 5AM Partners VI, LLC | 10% owner | Converted | 7.3M | 2.4M | SEC | ||
| Aug 10, 2026 | Aug 12, 2026 | LTGO | Sanofi | 10% owner | ConvertedSeries B Preferred Stock | 672,778 | 0 | SEC | ||
| Aug 10, 2026 | Aug 12, 2026 | LTGO | Sanofi | 10% owner | Converted | 672,778 | 672,788 | SEC | ||
| Aug 10, 2026 | Aug 10, 2026 | LTGO | Seidenberg Beth C | Director, 10% owner | ConvertedSeries Seed Convertible Stock | 12.7M | 0 | SEC | ||
| Aug 10, 2026 | Aug 10, 2026 | LTGO | Seidenberg Beth C | Director, 10% owner | Converted | 12.7M | 2.1M | SEC | ||
| Aug 10, 2026 | Aug 11, 2026 | LTGO | Westlake BioPartners GP I, LLC | 10% owner | ConvertedSeries Seed Convertible Preferred Stock | 12.7M | 0 | SEC | ||
| Aug 10, 2026 | Aug 11, 2026 | LTGO | Westlake BioPartners GP I, LLC | 10% owner | Converted | 12.7M | 2.1M | SEC | ||
| Aug 10, 2026 | Aug 10, 2026 | LTGO | Foresite Capital Fund VI LP | 10% owner | Bought | 140,000 | $18.00 | $2.5M | 2M | SEC |
| Aug 10, 2026 | Aug 10, 2026 | LTGO | Foresite Capital Fund VI LP | 10% owner | ConvertedSeries A-2 Convertible Preferred Stock | 9M | 0 | SEC | ||
| Aug 10, 2026 | Aug 10, 2026 | LTGO | Foresite Capital Fund VI LP | 10% owner | Converted | 9M | 3.4M | SEC | ||
| Aug 6, 2026 | Aug 10, 2026 | LTGO | Smith Todd N | Director | AwardedDirector Stock Option (right to buy) | 105,542 | 105,542 | SEC |